We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ARDX market cap is 1.23B. The company's latest EPS is USD -0.2789 and P/E is -18.61.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 56.39M | 34.36M | 46.02M | 73.22M | 98.24M |
| Operating Income | 7.4M | -27.99M | -24.68M | -13.63M | 2.23M |
| Net Income | 6.63M | -28.8M | -26.52M | -16.45M | -809k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.28M | 7.57M | 10.1M | 52.16M | 124.46M |
| Operating Income | -91.26M | -90.78M | -154.35M | -63.76M | -63.28M |
| Net Income | -94.94M | -94.31M | -158.17M | -67.21M | -66.07M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 289.38M | 297.58M | 342.38M | 343.49M | 367.86M |
| Total Liabilities | 98.22M | 130.76M | 191.49M | 196.5M | 209.57M |
| Total Equity | 191.16M | 166.82M | 150.89M | 146.99M | 158.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 259.78M | 201.56M | 149.91M | 190.07M | 297.58M |
| Total Liabilities | 73.13M | 75.45M | 67.3M | 91.74M | 130.76M |
| Total Equity | 186.66M | 126.11M | 82.62M | 98.33M | 166.82M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -81M | -89.72M | -35.72M | -55.12M | -54.62M |
| Investing | -101.68M | -131.25M | -2.57M | 20.96M | 23.3M |
| Financing | 120.31M | 146.3M | 52.97M | 54.58M | 57.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -76.48M | -81.44M | -152.55M | -70.04M | -89.72M |
| Investing | 23.37M | -31.44M | 50.95M | 18.42M | -131.25M |
| Financing | 155.48M | 22.78M | 83M | 75.34M | 146.3M |
| Market Cap | 1.23B |
| Price to Earnings Ratio | -18.61 |
| Price to Sales Ratio | 9.88 |
| Price to Cash Ratio | 57.28 |
| Price to Book Ratio | 7.37 |
| Dividend Yield | - |
| Shares Outstanding | 236.85M |
| Average Volume (1 week) | 4.86M |
| Average Volume (1 Month) | 4.31M |
| 52 Week Change | -15.72% |
| 52 Week High | 10.13 |
| 52 Week Low | 4.32 |
| Spread (Intraday) | 0.01 (0.19%) |
| Company Name | Ardelyx Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.ardelyx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
